While exome sequencing did not find mutations in ZHX2 in patients with primary glomerular disease (22, 23), insertions and deletions (InDels) were discovered far upstream of ZHX2 in patients with MCD and FSGS (6). This evidence concerns the gene ZHX2 and focal segmental glomerulosclerosis.